Fairvalue-Calculator Fairvalue-Calculator
EN DE

SYN-TECH Chem. & Pharm. Co (1777) Fair Value & Analysis

Healthcare · TW · Market cap 3.2B TWD

Price72.40 TWD
Fair Value129.07 TWD
Upside+78.3%
Quality95/100
Evidence: High Range 96.80 TWD – 161.33 TWD

Fair value as of: Jun 24, 2026

Analysis

SYN-TECH Chem. & Pharm. Co (1777) currently trades at 72.40 TWD, while our model-based Fair Value estimate is 129.07 TWD — implying the stock looks roughly 78.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, a-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. SYN-TECH Chem. & Pharm. Co., L…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is SYN-TECH Chem. & Pharm. Co (1777) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 129.07 TWD versus a price of 72.40 TWD — about +78% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 1777?
Our 21-model fair value for SYN-TECH Chem. & Pharm. Co is 129.07 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 72.40 TWD.
What is the quality score of 1777?
SYN-TECH Chem. & Pharm. Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.